Welcome to Greenshoots

The virtual ‘courtroom’ experience at the IPEC

In June and July 2020, Appleyard Lees litigated an unprecedented number of trials in the Intellectual Property Enterprise Court (IPEC) – which were held in an equally unprecedented, virtual format.

The Greenshoots Podcast by Appleyard Lees Episode eight: virtual trials at the Intellectual Property Enterprise Court (IPEC)

The Greenshoots Podcast by Appleyard Lees – episode 7 – tech transfer teams’ IP challenges post-COVID and beyond

Tech transfer teams’ IP challenges post-COVID and beyond: Collaboration/inventorship/ownership | FTOs | Cost pressures | Funding | IP Strategy | Commercialisation strategy | Plausibility and Sufficiency | Multidisciplinary teams | Priority | Trade marks and other commercial considerations

The Greenshoots Podcast by Appleyard Lees – episode 6 – challenges and shifting priorities for in-house inventors and IP teams post COVID-19 and beyond

Partners and patent attorneys Ean Davies and Adam Tindall discuss: Reimagining the in-house team/outside counsel relationship | Getting the best from private practice IP attorneys | IP during a recession

Unregistered design rights: is there still any point?

Unregistered design rights (UDR) protects the shape or configuration of the whole or part of an article, excluding surface decoration. The design must be original and must not be commonplace.

Are digital twins as patentable as their physical counterparts?

We live in an increasingly digital world – not only do more of us communicate with each other and access information or content using ‘apps’ and the internet, but some of the work we may have previously conducted in the ‘real’ or physical world is now being performed using computer simulations or digital twins.

Finding the ‘right’ slogan: FMCG sector to “Have a break” after all…

In the United Kingdom and European Union, it is notoriously difficult to register slogans as trade marks. To stand a chance of success, brand owners must prepare their case

CRISPR: An update

What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA sequences found in bacteria.

What’s the scoop on the Mr Whippy decision?

Despite “convincing arguments” against the strength of the evidence of use submitted by Unilever Plc, following the close-cut decision of the IPO on the 11 November 2019, the applicants’

The Greenshoots Podcast by Appleyard Lees – episode five – features of EPO virtual opposition hearings

Partners and patent attorneys Julia Gwilt and Bobby Smithson discuss: Features of EPO virtual opposition hearings | Unexpected pros | Discreet communication between attorney, client and witness | Learnings & tips | ‘Reading the room’ | Procedural quirks | Would the outcome have been different if parties attended in person?

Sufficiency at the UK Supreme Court in Regeneron Pharmaceuticals Inc v Kymab Ltd

The UK Supreme Court handed down the judgment in a much anticipated biotech decision on 24 June. The Court found that Regeneron’s patents are invalid for lack of sufficient disclosure.